Tamoxifen Clinical Trials Tamoxifen RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
Condition:   Breast Neoplasms Interventions:   Drug: Imlunestrant;   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane Sponsor:   Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2022 Category: Research Source Type: clinical trials

TREAT ctDNA Elacestrant
Conditions:   ER-positive Breast Cancer;   HER2-negative Breast Cancer;   Stage IIB Breast Cancer;   Stage III Breast Cancer Interventions:   Drug: Elacestrant;   Drug: Tamoxifen;   Drug: Letrozole 2.5mg;   Drug: Anastrozole 1mg;   Drug: Exemestane 25 MG Sponsors:   European Organisation for Research and Treatment of Cancer - EORTC;   Breast International Group;   Menarini Group Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2022 Category: Research Source Type: clinical trials